 role endogenous gonadotropin release etiology ovarian enlargement purified urinary follicle-stimulating hormone therapy Patients polycystic ovarian disease groups maximum ovarian diameter maxD ovulation induction purified urinary follicle-stimulating hormone FSH Serum hormone LH FSH radioimmunoassay size number follicles ultrasonography hormone group equal group equal mm mm last days treatment FSH rise group FSH accumulation study pharmacodynamics endogenous origin hormone days administration human chorionic gonadotropin hCG groups number follicles group hCG administration group Any significant differences total amount purified urinary FSH basal FSH LH levels treatment groups results excessive ovarian enlargement gonadotropin therapy multiple follicular development endogenous FSH Endogenous LH release enhances ovarian enlargement